Literature DB >> 8458500

Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells.

H E Guerrero1, P Stein, R H Asch, E P de Fried, M Tesone.   

Abstract

OBJECTIVE: To examine the effect of a gonadotropin-releasing hormone agonist (GnRH-a), leuprolide acetate (LA), on human chorionic gonadotropin/luteinizing hormone (LH) receptors content and progesterone (P) and estradiol (E2) production in cultured granulosa or luteal cells.
DESIGN: Prospective.
SETTING: Private Fertility Clinic and National Research Institute. PATIENTS: Twenty patients undergoing in vitro fertilization or gamete intrafallopian transfer programs.
RESULTS: Human chorionic gonadotropin/LH receptors in human granulosa cells increased after 48 hours of culture, and LA inhibited such effect. Leuprolide acetate, 1 ng/mL, in the cultures produced an increase in P production. On the contrary, LA inhibited E2 production. Additionally, the in vivo effect of LA (2 micrograms/rat per 7 days) was studied in corpus luteum of superovulated rats. Luteal cells from LA-treated rats in culture produced lower P than the controls but showed an increase in aromatase activity. Luteal LH receptors declined after 48 hours of culture with LA.
CONCLUSION: The high doses of gonadotropin necessary to induce ovarian hyperstimulation when GnRH-a is administered could be related with an inhibitory effect of these agonists on LH receptors and aromatase activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458500

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Regulation of ovarian follicle differentiation in gonadotrophin-stimulated rats.

Authors:  C V Andreu; C A Buscaglia; F Parborell; P Stein; M Tesone
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

2.  The effect of leuprorelin on steroidogenesis of human preovulatory granulosa cells in vitro.

Authors:  R Fabbri; E Porcu; A Pession; E Sereni; T Marsella; R Seracchioli; C Flamigni
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

Review 3.  Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.

Authors:  Luiz Eduardo T Albuquerque; Leopoldo O Tso; Humberto Saconato; Maria Cecília R M Albuquerque; Cristiane R Macedo
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

4.  Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro.

Authors:  Mohamed F M Mitwally; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2002-08       Impact factor: 3.412

Review 5.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

6.  Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation.

Authors:  Yu Li; Dongzi Yang; Qingxue Zhang
Journal:  J Hum Reprod Sci       Date:  2012-01

7.  Effects of Different Exposure Days to Gonadotropin-Releasing Hormone Agonist (GnRH-a) on Live Birth Rates in the Depot GnRH-a Protocol: A Retrospective Analysis of 7007 Cycles.

Authors:  Jianyuan Song; Wei Wu; Liu Jiang; Cuicui Duan; Jian Xu
Journal:  Med Sci Monit       Date:  2021-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.